Novotech is featured in The Next Frontier, a global series presented by Biotechnology Innovation Organization (BIO) and produced for them by BBC StoryWorks Commercial Productions. The series explores how biotechnology is transforming complex science into real-world solutions to address the world’s most urgent health and sustainability challenges.
As part of the series, Novotech focuses on one of the greatest unmet medical needs: finding a cure for Hepatitis B, a chronic disease affecting nearly 300 million people globally.
Accelerating the Path to a Hepatitis B Cure
Filmed in New Zealand recognized for its early-phase research capabilities and efficient regulatory environment the film showcases how Novotech accelerates biotech and small to mid-size pharma innovation through a true partnership model. With over 100,000 people living with Hepatitis B in New Zealand alone, the location reflects both the need and the opportunity for rapid scientific advancement.
Why It Matters for Biotech and Pharma Sponsors
Finding a cure for Hepatitis B requires more than science it demands the right partners, infrastructure, and access. Novotech enables biotech and small and mid-size pharma sponsors to launch studies faster with:
- Proven access to trial-ready patient populations
- A network of experienced principal investigators
- Streamlined trial startup across Asia-Pacific, North America and Europe
This isn’t just a story it’s a look into how Novotech operationalizes clinical innovation to align sponsor vision with patient impact.